Arlene Morris

Arlene Morris

Fortune : 11 651 $ au 31/05/2026

74 ans
Health Technology
Commercial Services
Consumer Services

Profil

Arlene M.
Morris
currently works at Willow Advisors LLC, as Chief Executive Officer from 2015, Medical University of South Carolina Foundation, as Chairman-Research & Development Foundation, TC Biopharm (Holdings) Plc, as Chairman from 2023, Palatin Technologies, Inc., as Independent Director from 2015, Viveve, Inc., as Independent Director from 2016, Cogent Biosciences, Inc., as Independent Director from 2019, Viridian Therapeutics, Inc., as Independent Director from 2018, Charleston Animal Society, as Director from 2022, and Edgewise Therapeutics, Inc., as Independent Director from 2024.
Ms. Morris also formerly worked at Syndax Pharmaceuticals, Inc., as President, Chief Executive Officer & Director from 2012 to 2015, Affymax, Inc., as President, Chief Executive Officer & Director from 2003 to 2011, Clearview Projects, Inc., as President & Chief Executive Officer from 2002 to 2004, Nuon Therapeutics, Inc., as Chairman, MediciNova, Inc., as Independent Director from 2011 to 2013, Biodel, Inc., as Director from 2015 to 2016, Biotechnology Innovation Organization, as Director from 2006 to 2011, MUSC Foundation for Research Development, as Director from 2012 to 2022, Humane Society of Silicon Valley, as Director from 2009 to 2011, Dimension Therapeutics, Inc., as Independent Director from 2015 to 2018, Neovacs, Inc., as Director from 2011 to 2021, Viveve Medical, Inc., as Independent Director from 2016 to 2022, Neovacs SA, as Independent Director from 2011 to 2021, Coulter Pharmaceuticals, Inc., as Senior Vice President-Business Development from 1996 to 2001, Carlow University Of, as Trustee from 2016 to 2022, Scios, Inc., as Senior Vice President-Business Development from 1993 to 1996, and Johnson & Johnson, as Vice President-Business Development from 1977 to 1993.
Ms. Morris received her undergraduate degree from Carlow College and undergraduate degree from Western New England University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
09/12/2025 831 ( 0,05 % ) 11 651 $ 31/05/2026
09/06/2026 0 ( -.--% ) - $ 31/05/2026
07/05/2025 0 ( -.--% ) - $ 31/03/2026
31/03/2026 0 ( -.--% ) - $ 31/05/2026
05/06/2026 0 ( -.--% ) - $ 31/05/2026

Postes actifs de Arlene Morris

SociétésPosteDébut
PALATIN TECHNOLOGIES, INC. Directeur/Membre du Conseil 01/06/2015
VIRIDIAN THERAPEUTICS, INC. Directeur/Membre du Conseil 03/01/2018
COGENT BIOSCIENCES, INC. Directeur/Membre du Conseil 26/07/2019
TC BIOPHARM (HOLDINGS) PLC Président 14/02/2023
EDGEWISE THERAPEUTICS, INC. Directeur/Membre du Conseil 06/05/2024
Directeur/Membre du Conseil 01/04/2022
Corporate Officer/Principal -
Directeur/Membre du Conseil 01/05/2016
Directeur Général 01/05/2015

Anciens postes connus de Arlene Morris

SociétésPosteFin
░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Arlene Morris

Formation de Arlene Morris

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

61

Relations au 1er degré

28

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées28

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Clearview Projects, Inc.

MUSC Foundation for Research Development

Health Technology

Commercial Services

Miscellaneous

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

  1. Bourse
  2. Insiders
  3. Arlene Morris
🔇